MediciNova Statistics
Total Valuation
MediciNova has a market cap or net worth of $63.76 million. The enterprise value is $14.06 million.
| Market Cap | 63.76M |
| Enterprise Value | 14.06M |
Important Dates
The next estimated earnings date is Thursday, May 9, 2024, after market close.
| Earnings Date | May 9, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MediciNova has 49.05 million shares outstanding. The number of shares has increased by 0.00% in one year.
| Shares Outstanding | 49.05M |
| Shares Change (YoY) | +0.00% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 2.56% |
| Owned by Institutions (%) | 21.14% |
| Float | 42.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 64.84 |
| Forward PS | n/a |
| PB Ratio | 1.04 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 14.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.61, with a Debt / Equity ratio of 0.00.
| Current Ratio | 15.61 |
| Quick Ratio | n/a |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -13.20% and return on invested capital (ROIC) is -15.82%.
| Return on Equity (ROE) | -13.20% |
| Return on Assets (ROA) | -12.50% |
| Return on Capital (ROIC) | -15.82% |
| Revenue Per Employee | $76,923 |
| Profits Per Employee | -$659,347 |
| Employee Count | 13 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MediciNova has paid $3,047 in taxes.
| Income Tax | 3,047 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.45% in the last 52 weeks. The beta is 0.69, so MediciNova's price volatility has been lower than the market average.
| Beta (1Y) | 0.69 |
| 52-Week Price Change | -39.45% |
| 50-Day Moving Average | 1.40 |
| 200-Day Moving Average | 1.80 |
| Relative Strength Index (RSI) | 37.37 |
| Average Volume (30 Days) | 49,791 |
Short Selling Information
The latest short interest is 246,988, so 0.50% of the outstanding shares have been sold short.
| Short Interest | 246,988 |
| Short Previous Month | 333,637 |
| Short % of Shares Out | 0.50% |
| Short % of Float | 0.58% |
| Short Ratio (days to cover) | 4.41 |
Income Statement
In the last 12 months, MediciNova had revenue of $1.00 million and -$8.57 million in losses. Loss per share was -$0.17.
| Revenue | 1.00M |
| Gross Profit | 1.00M |
| Operating Income | -9.90M |
| Pretax Income | -8.57M |
| Net Income | -8.57M |
| EBITDA | -8.35M |
| EBIT | -8.57M |
| Loss Per Share | -$0.17 |
Balance Sheet
The company has $51.00 million in cash and $215,926 in debt, giving a net cash position of $50.78 million or $1.04 per share.
| Cash & Cash Equivalents | 51.00M |
| Total Debt | 215,926 |
| Net Cash | 50.78M |
| Net Cash Per Share | $1.04 |
| Equity / Book Value | 62.38M |
| Book Value Per Share | 1.27 |
| Working Capital | 47.90M |
Cash Flow
In the last 12 months, operating cash flow was -$7.43 million and capital expenditures -$21,299, giving a free cash flow of -$7.45 million.
| Operating Cash Flow | -7.43M |
| Capital Expenditures | -21,299 |
| Free Cash Flow | -7.45M |
| FCF Per Share | -$0.15 |
Margins
Gross margin is 100.00%, with operating and profit margins of -990.03% and -857.15%.
| Gross Margin | 100.00% |
| Operating Margin | -990.03% |
| Pretax Margin | -856.85% |
| Profit Margin | -857.15% |
| EBITDA Margin | -835.37% |
| EBIT Margin | -856.85% |
| FCF Margin | -745.23% |
Dividends & Yields
MediciNova does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.00% |
| Shareholder Yield | -0.00% |
| Earnings Yield | -13.22% |
| FCF Yield | -11.49% |
Analyst Forecast
| Price Target | n/a |
| Price Target Difference | n/a |
| Analyst Consensus | n/a |
| Analyst Count | n/a |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on October 31, 2006. It was a reverse split with a ratio of 1:10.
| Last Split Date | Oct 31, 2006 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MediciNova has an Altman Z-Score of 1.67 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.67 |
| Piotroski F-Score | 1 |